The Center for Celiac Research at Massachusetts General Hospital, MassGeneral Hospital for Children, and the Celiac Research Program at Harvard Medical School, recently launched the Celiac Disease Genomic Environmental Microbiome and Metabolomic Study (CDGEMM) to understand the role that our genes, our gut microbiome, and environmental factors play in the development of celiac disease. 200 babies are currently enrolled in the study, and researchers are seeking an additional 300 infants.
5/25/2017
Celiac Disease Study for Infants – Enroll Your Child Today!
Recent Posts
- Advocacy Spotlight: How One Arizona Teen Helped Expand Gluten-Free Food Access Through the CD-FIRN Program
- Celiac Disease Foundation Advances Research, Policy, and Global Patient Leadership at ICDS 2026
- Teva Pharmaceuticals Announces Positive Phase 2a Results for Investigational Celiac Disease Treatment
- The Emerald Benefit: A Shining Example of Celiac Disease Advocacy
Search the archive
Categories
- Advocacy News
- Celiac Disease in the News
- Clinical Trials
- Community Spotlight
- Eat! Gluten-Free
- Featured
- Foundation Press
- iCureCeliac
- Impact Fund
- Marilyn’s Message
- Monthly eNewsletter
- Patient Profile Advocacy Series
- Recipes
- Research
- Research News
- Trending Topics
Marilyn's Message
3/18/2025
Read moreA Bold New Look for the Celiac Disease Foundation